Docoh
Loading...

OSMT Osmotica Pharmaceuticals

News

From Benzinga Pro
Osmotica Pharmaceuticals Q3 EPS $(0.42) Misses $(0.36) Estimate, Sales $2.20M Miss $2.35M Estimate
15 Nov 21
Earnings, News
Osmotica Pharmaceuticals (NASDAQ:OSMT) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.36) by 16.67 percent. This is a 200 percent decrease over losses of $(0.14) per
Earnings Scheduled For November 15, 2021
15 Nov 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter.
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
14 Nov 21
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, Top Stories
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.
12 Health Care Stocks Moving In Wednesday's After-Market Session
27 Oct 21
Movers
Gainers
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
8 Oct 21
Biotech, News, Penny Stocks, Guidance, Offerings, Small Cap, FDA, IPOs, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7)
45 Biggest Movers From Yesterday
8 Oct 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Camber Energy, Inc.. (NYSE: CEI) shares surged 95.9% to close at $1.78 on Thursday after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial statements of Viking.
Mid-Afternoon Market Update: Crude Oil Rises 1%; New Fortress Energy Shares Spike Higher
7 Oct 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Thursday, the Dow traded up 1.29% to 34,860.01 while the NASDAQ rose 1.47% to 14,714.54. The S&P also rose, gaining 1.22% to 4,416.63.
12 Health Care Stocks Moving In Thursday's Intraday Session
7 Oct 21
Intraday Update, Markets, Movers
Mid-Day Market Update: Dow Jumps Over 500 Points; Osmotica Pharmaceuticals Shares Slide
7 Oct 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Midway through trading Thursday, the Dow traded up 1.51% to 34,938.25 while the NASDAQ rose 1.64% to 14,739.43. The S&P also rose, gaining 1.41% to 4,425.22.
28 Stocks Moving In Thursday's Mid-Day Session
7 Oct 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Camber Energy, Inc.. (NYSE: CEI) jumped 44.2% to $1.3102 after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial statements of Viking.
Mid-Morning Market Update: Markets Open Higher; Conagra Brands Profit Beats Views
7 Oct 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Following the market opening Thursday, the Dow traded up 1.51% to 34,936.37 while the NASDAQ rose 1.56% to 14,728.21. The S&P also rose, gaining 1.45% to 4,426.68.
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
7 Oct 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
7 Oct 21
Pre-Market Outlook, Markets, Movers
18 Stocks Moving in Thursday's Pre-Market Session
7 Oct 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Cyren Ltd. (NASDAQ: CYRN) rose 59.5% to $0.777 in pre-market trading after the company announced Nasdaq granted its request for a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement.
Osmotica Under Pressure On $35M Equity Raise To Pay Off Debt
7 Oct 21
Biotech, News, Penny Stocks, Health Care, Financing, Offerings, Movers, Trading Ideas, General
Osmotica Pharmaceuticals Priced 14M Share Underwritten Public Offering @$2.50/Share + Warrant
7 Oct 21
News, Penny Stocks, Offerings
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) ("Osmotica" or the "Company"), a specialty pharmaceutical company, today announced the pricing of its previously announced underwritten public offering of 14,000,000 ordinary shares of the Company and warrants to purchase up to 14,000,000 ordinary shares at a public offering price of
12 Health Care Stocks Moving In Wednesday's After-Market Session
6 Oct 21
Movers
Gainers TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 5.4% to $2.73 during Wednesday's after-market session. The company's market cap stands at $35.2 million.
Osmotica Pharmaceuticals's Return On Capital Employed Insights
4 Oct 21
Earnings
Osmotica Pharmaceuticals (NASDAQ:OSMT) brought in sales totaling $11.51 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 70.39%, resulting in a loss of $20.18 million.
Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021
24 Sep 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Upgrades
Cantor Fitzgerald Initiates Coverage On Osmotica Pharmaceuticals with Overweight Rating, Announces Price Target of $6
24 Sep 21
News, Price Target, Initiation, Analyst Ratings
Cantor Fitzgerald analyst Louise Chen initiates coverage on Osmotica Pharmaceuticals (NASDAQ:OSMT) with a Overweight rating and announces Price Target of $6.

Press releases

From Benzinga Pro
Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021
15 Nov 21
News, Press Releases
BRIDGEWATER, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (NASDAQ:OSMT) ("Osmotica" or the "Company"), a specialty pharmaceutical company, announced today that Brian Markison, Chief Executive
Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Update on November 15, 2021
11 Nov 21
News, Press Releases
BRIDGEWATER, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (NASDAQ:OSMT) ("Osmotica" or the "Company"), a specialty pharmaceutical company, today announced that the Company will release its 2021
Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public Offering
13 Oct 21
Markets, Press Releases
BRIDGEWATER, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (NASDAQ:OSMT) ("Osmotica" or the "Company"), a specialty pharmaceutical company, today announced that on October 12, 2021, it closed its
Thinking about buying stock in Camber Energy, Bit Digital, Brickell Biotech, Osmotica Pharmaceuticals, or SmileDirectClub?
7 Oct 21
Fintech, Opinion, Press Releases
NEW YORK, Oct. 7, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CEI, BTBT, BBI, OSMT, and SDC.
Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 Million
7 Oct 21
News, Financing, Press Releases
BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (NASDAQ:OSMT) ("Osmotica" or the "Company"), a specialty pharmaceutical company, today announced that it has entered into a note
Osmotica Pharmaceuticals Announces Pricing of $35 Million Underwritten Public Offering
7 Oct 21
Markets, Press Releases
BRIDGEWATER, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (NASDAQ:OSMT) ("Osmotica" or the "Company"), a specialty pharmaceutical company, today announced the pricing of its previously announced
Osmotica Pharmaceuticals plc Announces Proposed Underwritten Public Offering
6 Oct 21
Press Releases
BRIDGEWATER, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (NASDAQ:OSMT) ("Osmotica" or the "Company"), a specialty pharmaceutical company, today announced that it has commenced an underwritten
Osmotica Pharmaceuticals plc to Present at Cantor Virtual Global Healthcare Conference 2021
22 Sep 21
News, Press Releases
BRIDGEWATER, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (NASDAQ:OSMT) ("Osmotica" or the "Company"), a specialty pharmaceutical company, announced today that Brian Markison, Chief Executive